For: | Carmona-sánchez R, Icaza-chávez M, Bielsa-fernández M, Gómez-escudero O, Bosques-padilla F, Coss-adame E, Esquivel-ayanegui F, Flores-rendón Á, González-martínez M, Huerta-iga F, López-colombo A, Méndez-gutiérrez T, Noble-lugo A, Nogueira-de Rojas J, Raña-garibay R, Remes-troche J, Roesch-dietlen F, Schmulson M, Soto-pérez J, Tamayo J, Uscanga L, Valdovinos M, Valerio-ureña J, Zavala-solares M. Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 2016;81:149-67. [DOI: 10.1016/j.rgmx.2016.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Rajbanshi B, Das K, Roy D, Saha S, Nath Roy M. Exploring 2:1 Inclusion Complexes of cyclodextrins and Antispasmodics, Alverine citrate for Enhancing bioavailability and Sustained Dischargement. Journal of Molecular Liquids 2022. [DOI: 10.1016/j.molliq.2022.121036] [Reference Citation Analysis] |
2 | Shah K, Ramos-Garcia M, Bhavsar J, Lehrer P. Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis. Behav Res Ther 2020;128:103462. [PMID: 32229334 DOI: 10.1016/j.brat.2019.103462] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis] |
3 | An Y, Prince D, Gardiner F, Neeman T, Linedale EC, Andrews JM, Connor S, Begun J. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis. Medical Journal of Australia 2019;211:461-7. [DOI: 10.5694/mja2.50384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis] |